Axsome Therapeutics (AXSM) had the highest return between October 1, 2019 and December 31, 2019 by a mid-cap US stock, returning 410.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | 10/1/2019 - 12/31/2019 | 410.42% |
Intracellular Th (ITCI) | 10/1/2019 - 12/31/2019 | 360.54% |
Immunitybio (IBRX) | 10/1/2019 - 12/31/2019 | 208.13% |
Nio Inc Class A ADR (NIO) | 10/1/2019 - 12/31/2019 | 166.23% |
Mirum Pharmaceuticals (MIRM) | 10/1/2019 - 12/31/2019 | 145.45% |
Bloom Energy (BE) | 10/1/2019 - 12/31/2019 | 129.14% |
Arrowhead Pharmaceuticals (ARWR) | 10/1/2019 - 12/31/2019 | 125.73% |
Surgery Partners (SGRY) | 10/1/2019 - 12/31/2019 | 112.13% |
TG Therapeutics (TGTX) | 10/1/2019 - 12/31/2019 | 96.81% |
Sitime (SITM) | 10/1/2019 - 12/31/2019 | 96.15% |
Soleno Therapeutics (SLNO) | 10/1/2019 - 12/31/2019 | 96% |
Hecla Mining (HL) | 10/1/2019 - 12/31/2019 | 90.68% |
Sibanye Gold Ltd ADR (SBSW) | 10/1/2019 - 12/31/2019 | 81.2% |
SpringWorks Therapeutics (SWTX) | 10/1/2019 - 12/31/2019 | 78.77% |
Central Puerto (CEPU) | 10/1/2019 - 12/31/2019 | 70.34% |
Coeur Mining (CDE) | 10/1/2019 - 12/31/2019 | 70.11% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 10/1/2019 - 12/31/2019 | 65.07% |
Synaptics (SYNA) | 10/1/2019 - 12/31/2019 | 64.38% |
BridgeBio Pharma (BBIO) | 10/1/2019 - 12/31/2019 | 63.18% |
Crinetics Pharmaceuticals (CRNX) | 10/1/2019 - 12/31/2019 | 63.13% |
Krystal Biotech (KRYS) | 10/1/2019 - 12/31/2019 | 61.08% |
Immunovant (IMVT) | 10/1/2019 - 12/31/2019 | 58.38% |
Vipshop (VIPS) | 10/1/2019 - 12/31/2019 | 57.97% |
Gerdau SA ADR (GGB) | 10/1/2019 - 12/31/2019 | 57.47% |
Vicor (VICR) | 10/1/2019 - 12/31/2019 | 57.09% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
